In Focus: Raw materials
As cell therapies progress from the lab to the clinic, the raw material requirements change. In the clinical and commercial stages they need to meet higher safety and quality conditions to ensure patient safety and regulatory compliance. So how do you select the right raw materials for the different stages of your process?
In this In Focus feature, we explore this question and investigate methods to reliably test raw materials, such as cytokines, from different suppliers. We’ll also share top tips from experts at Sartorius CellGenix (Freiburg, Germany) on how to make your transition into GMP manufacturing as smooth as possible.
Infographic
Cytokines for cell and gene therapy: from research to commercialization
This infographic explains how to select the right cytokines for each stage of your cell therapy development and manufacturing journey. Plus, it lays out methods and top tips for demonstrating reproducibility and comparability when assessing cytokine activity.
Interview
In this interview, we spoke with Bernd Leistler about the significance of raw materials in the development and manufacturing of cell and gene therapies and how product requirements change when transitioning from research to preclinical development and beyond to the clinical and commercial manufacturing phases.
In association with
